EtNoHep’s contribution to new WHO hepatitis B guidelines

The establishment of EtNoHep was primarily motivated by the lack of African-based evidence in international hepatitis B treatment guidelines. With 254 million people living with chronic hepatitis B infection, the WHO aims to reduce new infections by 90% and deaths by 65% within 2030. Sub-Saharan Africa has the highest prevalence...

Read more...

EtNoHep at the EASL Congress 2024

EtNoHep members were represented at the European Association for the Study of the Liver (EASL) Congress 2024. The Congress was held in Milano from 5-8 June, and brought together more than 7,000 professionals to explore the latest research in the field of hepatology. Viral hepatitis was an important part of...

Read more...